We are live on ! Find out more
FLXN

Flexion Therapeutics, Inc.
FLXN

Delisted

FLXN was delisted on the 18th of November, 2021.

Back to rankings

116 hedge funds and large institutions have $660M invested in Flexion Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 8

24% more capital invested

Capital invested by funds: $532M → $660M (+$128M)

16% more funds holding

Funds holding: 100 → 116 (+16)

14% more call options, than puts

Call options by funds: $14.2M | Put options by funds: $12.5M

3% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
116
Holders Change
+16
Holders Change %
+16%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
34
Reduced
33
Closed
8
Calls
$14.2M
Puts
$12.5M
Net Calls
+$1.7M
Net Calls Change
+$2.94M

Top Buyers

Rank Fund Capital Flow
1
MVP
Miller Value Partners
Florida
+$15.4M
2
GS
Gagnon Securities
New York
+$3.39M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
+$3.1M
4
UIC
Uniplan Investment Counsel
Wisconsin
+$2.91M
5
Russell Investments Group
Russell Investments Group
United Kingdom
+$2.88M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$7.18M
2
ZDA
Zweig-DiMenna Associates
New York
-$3.78M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.76M
4
PCM
Peregrine Capital Management
Minnesota
-$2.68M
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$2.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
GS
26
Gagnon Securities
New York
$3.49M +$3.39M +144,331 New
Allianz Asset Management
27
Allianz Asset Management
Germany
$3.28M -$456K -19,413 -13%
GH
28
GAM Holding
Switzerland
$3.15M – – –
Russell Investments Group
29
Russell Investments Group
United Kingdom
$3.08M +$2.88M +122,450 +2,459%
RJA
30
Raymond James & Associates
Florida
$3M +$91.3K +3,883 +3%
UIC
31
Uniplan Investment Counsel
Wisconsin
$3M +$2.91M +123,904 New
GA
32
Gagnon Advisors
New York
$2.62M +$2.55M +108,498 New
American Century Companies
33
American Century Companies
Missouri
$2.61M +$17K +724 +0.7%
Charles Schwab
34
Charles Schwab
California
$2.6M +$149K +6,336 +6%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$2.55M +$1.63M +69,401 +192%
PP
36
Peconic Partners
New York
$2.42M +$2.35M +100,000 New
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$1.95M -$6.86K -292 -0.4%
TCIM
38
TIAA CREF Investment Management
New York
$1.77M -$25K -1,063 -1%
CHP
39
Castle Hook Partners
New York
$1.77M +$1.72M +73,316 New
Morgan Stanley
40
Morgan Stanley
New York
$1.74M +$682K +29,028 +68%
RJFSA
41
Raymond James Financial Services Advisors
Florida
$1.73M +$183K +7,800 +12%
Citadel Advisors
42
Citadel Advisors
Florida
$1.4M +$1.37M +58,082 New
Goldman Sachs
43
Goldman Sachs
New York
$1.37M +$116K +4,953 +10%
SC
44
Scholtz & Company
Connecticut
$1.34M -$16.6K -705 -1%
CCM
45
Cadence Capital Management
Massachusetts
$1.31M +$61.4K +2,612 +5%
HCM
46
Highbridge Capital Management
New York
$1.23M +$960K +40,823 +408%
TA
47
Teachers Advisors
New York
$1.22M -$10.2K -434 -0.9%
RA
48
Royce & Associates
New York
$1.21M – – –
Macquarie Group
49
Macquarie Group
Australia
$1.14M -$210K -8,941 -16%
GC
50
Guggenheim Capital
Illinois
$1.09M -$358K -15,236 -25%
1
2
3 4 5

FLXN Hedge Fund Activity: Q3 2017 in Review

116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2017, worth a combined $660M — up 24% from $532M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new FLXN positions and 8 closed out — a net gain of 17 holders — while 34 added to existing stakes and 33 trimmed.

The largest buyer was Miller Value Partners, adding an estimated $15.4M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $7.18M.

  • 116 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2017, up from 100 in Q2 2017.
  • Funds reported $660M of Flexion Therapeutics, Inc. stock for Q3 2017, up 24% quarter-over-quarter.
  • 25 funds opened new Flexion Therapeutics, Inc. positions in Q3 2017 and 8 closed out, a net change of +17 holders.
  • The largest Flexion Therapeutics, Inc. buyer in Q3 2017 was Miller Value Partners, an estimated $15.4M added.
  • The largest Flexion Therapeutics, Inc. seller in Q3 2017 was Gilder Gagnon Howe & Co, an estimated $7.18M sold.

Based on aggregated 13F filings for Q3 2017.